Yttrium-90 radioembolization is a minimally invasive treatment that may slow disease progression in breast cancer that has metastasized to the liver.
A breast cancer therapy that blocks estrogen synthesis to activate cancer-killing genes sometimes loses its effectiveness because the cancer takes over epigenetic mechanisms, according to researchers.
High intake of saturated fat increases risk of HER2-negative, ER/PR-positive disease.
Faster and cheaper DNA sequencing techniques will likely improve care for patients with breast cancer but also create challenges for clinicians as they counsel patients on their treatment options.
The stiffening of breast tissue in breast-cancer development points to a new way to distinguish a type of breast cancer with a poor prognosis from a related but often less deadly type.
Clinical trial focusing on pre-surgery positron emission mammography. Pre-Surgery Positron Emission Mammography in Patients With Newly Diagnosed Breast Cancer
Clinical trial focusing on breast cancer information registry. A Breast Cancer Information Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer (BCCR)
Clinical trial focusing on breast density and breast cancer risk. Changes in Breast Density and Breast Cancer Risk in Women With Breast Cancer and in Healthy Women
Clinical trial focusing on genomic testing for primary breast cancer. Genomic Testing for Primary Breast Cancer
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|